Jade Biosciences, Inc. Common Stock JBIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$40.37M-5.8% | -$31.93M+32.0% | -$25.18M-54.7% | -$32.13M-5,346% | -$38.17M-64.6% | ||
| $9K+125% | $9K+12.5% | $12K-94.5% | $1K-96.4% | $4K-85.7% | ||
| $7.41M+206% | $9.4M+648% | $4.3M+15,807% | $3.9M+0.8% | $2.42M-42.3% | ||
| -$24.08M-28.4% | -$33.65M-48.8% | -$22.12M-225% | -$20.16M— | -$18.76M+20.8% | ||
| —— | $3K— | $57K— | $131K— | $5K— | ||
| -$8.47M-166% | -$98.16M-848% | -$148.71M— | -$12.99M— | $12.85M+45.5% | ||
| -$795K-13.6% | $170.16M+85.0% | $0-100% | $191.31M— | -$700K-249% | ||
| -$33.35M-71.4% | $38.33M-44.8% | -$170.84M-294% | $171.01M— | -$19.46M-35.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jade Biosciences, Inc. Common Stock generate?
- Jade Biosciences, Inc. Common Stock (JBIO) generated -$100.0M in operating cash flow over the trailing twelve months.
- What is Jade Biosciences, Inc. Common Stock's free cash flow?
- After $196.0K of capital expenditures, Jade Biosciences, Inc. Common Stock's free cash flow was -$94.9M over the trailing twelve months, down 66.7% year over year.
- Where does Jade Biosciences, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.